Healthcare facilities and services in India have been evolving with time and in recent years have been on a path of continuous development.Companies across this spectrum are ceaselessly striving to deliver the best of their potential in order to cater to the ever-increasing demands of the healthcare industry.
This edition, Best of 5 Regenerative Medicine Companies, places a spotlight on those companies that are bringing about profound changes and innovations in the sphere of regenerative medicine.One prominent name among these companies is Advancells, an India-based research-oriented company focused on regenerative medicine and its therapeutic applications.In the following interview with Insights Care, Vipul Jain, the CEO and Founder of Advancells Group shares with us in detail about the current landscape of the healthcare sector and how his company has gained a strong foothold within the same.Below are the highlights of the interview:Brief our readers about Advancells, its vision, and the key aspects of its strong position in the healthcare industry.Advancells Group is a multifaceted organization that focuses on cell culture research and stem cell therapeutics to encourage academic and industrial innovations in the healthcare domain.
An offshoot of the same, Advancells strongly believes that stem cell therapy and regenerative medicine can change the global viewpoint of medical healthcare in the years to come.Humankind is looking towards an era where personalized medicine will replace drugs, organ transplantation will be based on 3D printed organs, and aging will be a reversible process.
Advancells bridges this gap by creating regenerative therapy awareness and encouraging stem cell therapies.When it comes to our USPs, Advancells harbors cGMP certified cell culture laboratories and expert research personnel to ensure that our clients get the best quality of stem cells for therapy and research, besides other bioproducts like tissue-specific and disease-specific primary cells.When it comes to patient treatment and policies, with a gross 70% therapeutic success rate, many patients have found significant relief from disorders of osteoarthritis, diabetes, and ALS with stem cell therapy.The credit of Advancells being a preferred choice for stem cell therapy goes to our medical experts who play a major role in helping doctors, patients and caregivers in understanding the clinical potential of stem cell therapy.
Besides spending resources and time on vaccines and alternative therapies, many big firms have pushed a lot of effort into drug designing and repurposing.
And how are you strategizing your company’s operations for that future?As far as the healthcare industry is concerned, it is inevitable that the post-COVID-19 period is going to see a boom in business.Regarding the operations of Advancells, we have always been a step ahead in organizing and strategizing the market demands to maintain an optimum balance between business profits and social welfare through healthcare, even in times of a crisis.